Literature DB >> 10518567

Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.

N Leitinger1, T R Tyner, L Oslund, C Rizza, G Subbanagounder, H Lee, P T Shih, N Mackman, G Tigyi, M C Territo, J A Berliner, D K Vora.   

Abstract

We previously have demonstrated that oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC), a component of minimally modified low density lipoprotein (MM-LDL), activates endothelial cells to bind monocytes. 1-Palmitoyl-2- (5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) and 1- palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine (PGPC), which are present in OxPAPC, MM-LDL, and atherosclerotic lesions, were shown to have a major role in the activation of endothelial cells. We now demonstrate that these two highly similar molecules have dramatically different effects on leukocyte endothelial interactions. POVPC is a potent regulator of monocyte-specific endothelial interactions. Treatment of endothelial cells with POVPC increased monocyte binding by inducing the surface expression of the connecting segment 1 domain of fibronectin; no increase in neutrophil binding was observed. In addition, POVPC strongly inhibited lipopolysaccharide-mediated induction of neutrophil binding and expression of E-selectin protein and mRNA. This inhibition was mediated by a protein kinase A-dependent pathway, resulting in down-regulation of NF-kappaB-dependent transcription. In contrast, PGPC induced both monocyte and neutrophil binding and expression of E-selectin and vascular cell adhesion molecule 1. We present evidence to suggest that the two phospholipids act by different novel receptors present in Xenopus laevis oocytes and that POVPC, but not PGPC, stimulates a cAMP-mediated pathway. At concentrations equal to that present in MM-LDL, the effect of POVPC dominates and inhibits PGPC-induced neutrophil binding and E-selectin expression in endothelial cells. In summary, our data provide evidence that both POVPC and PGPC are important regulators of leukocyte-endothelial interactions and that POVPC may play a dominant role in a number of chronic inflammatory processes where oxidized phospholipids are known to be present.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518567      PMCID: PMC18403          DOI: 10.1073/pnas.96.21.12010

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Effects of defolliculation on membrane current responses of Xenopus oocytes.

Authors:  R Miledi; R M Woodward
Journal:  J Physiol       Date:  1989-09       Impact factor: 5.182

2.  Electrophysiological recording from Xenopus oocytes.

Authors:  W Stühmer
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

3.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung.

Authors:  Z Honda; M Nakamura; I Miki; M Minami; T Watanabe; Y Seyama; H Okado; H Toh; K Ito; T Miyamoto
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

4.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.

Authors:  M I Cybulsky; M A Gimbrone
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

5.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

Authors:  J A Berliner; M C Territo; A Sevanian; S Ramin; J A Kim; B Bamshad; M Esterson; A M Fogelman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Modification of the Recalde method for the isolation of human monocytes.

Authors:  A M Fogelman; F Elahi; K Sykes; B J Van Lenten; M C Territo; J A Berliner
Journal:  J Lipid Res       Date:  1988-09       Impact factor: 5.922

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.

Authors:  N Leitinger; A D Watson; S Y Hama; B Ivandic; J H Qiao; J Huber; K F Faull; D S Grass; M Navab; A M Fogelman; F C de Beer; A J Lusis; J A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

9.  Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1.

Authors:  J S Pober; M R Slowik; L G De Luca; A J Ritchie
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

10.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.

Authors:  N Kume; M I Cybulsky; M A Gimbrone
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more
  67 in total

1.  Synthesis and Identification of AceDoxyPC, a Protectin-Containing Structured Phospholipid, Using Liquid Chromatography/Mass Spectrometry.

Authors:  Amanda Lo Van; Baptiste Fourmaux; Madeleine Picq; Michel Guichardant; Michel Lagarde; Nathalie Bernoud-Hubac
Journal:  Lipids       Date:  2017-08-03       Impact factor: 1.880

2.  Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.

Authors:  Kenji Matsushita; Craig N Morrell; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

3.  Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.

Authors:  Elena Vladykovskaya; Evgeny Ozhegov; J David Hoetker; Zhengzhi Xie; Yonis Ahmed; Jill Suttles; Sanjay Srivastava; Aruni Bhatnagar; Oleg A Barski
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

4.  Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.

Authors:  Anna A Birukova; Elena Alekseeva; Ivan Cokic; Christopher E Turner; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

Review 5.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

6.  Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression.

Authors:  Markus Waldeck-Weiermair; Cristina Zoratti; Wolfgang F Graier; Karin Osibow; Nariman Balenga; Edith Goessnitzer; Maria Waldhoer; Roland Malli
Journal:  J Cell Sci       Date:  2008-04-29       Impact factor: 5.285

7.  Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.

Authors:  Jayasimha Rao; Antonio DiGiandomenico; Mykhaylo Artamonov; Norbert Leitinger; Ashok R Amin; Joanna B Goldberg
Journal:  Cell Immunol       Date:  2011-05-05       Impact factor: 4.868

8.  Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.

Authors:  Scott R Johnstone; Jeremy Ross; Michael J Rizzo; Adam C Straub; Paul D Lampe; Norbert Leitinger; Brant E Isakson
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 9.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

10.  Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.

Authors:  Christopher P Thomas; Lloyd T Morgan; Benjamin H Maskrey; Robert C Murphy; Hartmut Kühn; Stanley L Hazen; Alison H Goodall; Hassan A Hamali; Peter W Collins; Valerie B O'Donnell
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.